Prognosis
EU Review of Astra Vaccine Risks Finds 246 U.K. Adverse Events
- Safety committee will issue updated recommendation next week
- AstraZeneca shot’s benefits still outweigh its risks, EMA says
This article is for subscribers only.
The European Union’s drugs regulator said a link between AstraZeneca Plc’s Covid-19 vaccine and a rare type of blood clot is possible, identifying at least 62 cases of the condition while insisting the shot’s benefits still outweigh its risks.
The comments further cloud the picture around the vaccine after Germany restricted it to older people this week amid growing concerns about side effects. That could slow Europe’s already lagging immunization program as virus cases surge anew.